| 1 |
29329158 | Expression of Gastrin Family Peptides in Pancreatic Islets and Their Role in β-Cell Function and Survival. | 2018 Feb |
4 |
| 2 |
23055535 | Metabolic effects of activation of CCK receptor signaling pathways by twice-daily administration of the enzyme-resistant CCK-8 analog, (pGlu-Gln)-CCK-8, in normal mice. | 2013 Jan |
3 |
| 3 |
23164696 | Comparison of the independent and combined metabolic effects of subchronic modulation of CCK and GIP receptor action in obesity-related diabetes. | 2013 Aug |
3 |
| 4 |
23315994 | Beneficial effects of (pGlu-Gln)-CCK-8 on energy intake and metabolism in high fat fed mice are associated with alterations of hypothalamic gene expression. | 2013 Jun |
5 |
| 5 |
23388064 | Comparison of independent and combined metabolic effects of chronic treatment with (pGlu-Gln)-CCK-8 and long-acting GLP-1 and GIP mimetics in high fat-fed mice. | 2013 Jul |
7 |
| 6 |
23462797 | Comparison of the metabolic effects of sustained CCK1 receptor activation alone and in combination with upregulated leptin signalling in high-fat-fed mice. | 2013 Jun |
5 |
| 7 |
23583730 | (pGlu-Gln)-CCK-8[mPEG]: a novel, long-acting, mini-PEGylated cholecystokinin (CCK) agonist that improves metabolic status in dietary-induced diabetes. | 2013 Aug |
9 |
| 8 |
22814764 | Beneficial effects of the novel cholecystokinin agonist (pGlu-Gln)-CCK-8 in mouse models of obesity/diabetes. | 2012 Oct |
4 |